federica serino (@federicaserino) 's Twitter Profile
federica serino

@federicaserino

ID: 430285540

calendar_today07-12-2011 00:10:27

694 Tweet

138 Followers

245 Following

JIM Congress (@jimcongress) 's Twitter Profile Photo

🚨The countdown to #JIMGISE2025 is on! In just a few days, Rome will host #livecases, high-impact discussions and real-world challenges in interventional cardiology! 🫀Giuseppe_Tarantini , one of the Congress Director, will be among the experts shaping the future. See you there!🇮🇹

🚨The countdown to #JIMGISE2025 is on!

In just a few days, Rome will host #livecases, high-impact discussions and real-world challenges in interventional cardiology!

🫀<a href="/G_Tarantini01/">Giuseppe_Tarantini</a> , one of the Congress Director, will be among the experts shaping the future. 
See you there!🇮🇹
EAPCIPresident (@eapcipresident) 's Twitter Profile Photo

Sici GISE #EAPCI Joint Session at #JIM2025 🇮🇹 Thursday February 20 LUNCH SYMPOSIUM ⭐️Beyond Stents: Physiology &. Imaging for Complex Scenarios ⭐️New Recommendations from European Society of Cardiology CCS 2024 Guidelines Francesco Saia chief Emanuele Barbato MIЯVΛƬ #IC

<a href="/sicigise/">Sici GISE</a> #EAPCI Joint Session at #JIM2025 🇮🇹 

Thursday February 20 

LUNCH SYMPOSIUM 

⭐️Beyond Stents: Physiology &amp;. Imaging for Complex Scenarios 

⭐️New Recommendations from <a href="/escardio/">European Society of Cardiology</a> CCS 2024 Guidelines

<a href="/saia_francesco/">Francesco Saia</a> <a href="/alaide_chief/">chief</a> <a href="/EmanueleBarba13/">Emanuele Barbato</a> <a href="/mirvatalasnag/">MIЯVΛƬ #IC</a>
Marco Toselli (@mrctsl) 's Twitter Profile Photo

Fellow course JIM Congress: #1 teaching point from #JIMGISE2025: 🎙️”the use of IVI alone does not necessarily improve patients outcome if physician do not have the knowledge and skills to interpret the imaging and modify procedural strategy” Dott. Guagliumi

Fellow course <a href="/jimcongress/">JIM Congress</a>:

#1 teaching point from #JIMGISE2025:

🎙️”the use of IVI alone does not necessarily improve patients outcome if physician do not have the knowledge and skills to interpret the imaging and modify procedural strategy” Dott. Guagliumi
JIM Congress (@jimcongress) 's Twitter Profile Photo

💡Delve into Temporary Mechanical Circulatory Support with a Microaxial Flow Pump focusing on: 🔶Infarct-related cardiogenic shock 🔶Hemodynamic support in high-risk PCI 🔶LV dysfunction management 🔶Coordinated care through shock networks #JIMGISE2025 #interventionalcardiology

💡Delve into Temporary Mechanical Circulatory Support with a Microaxial Flow Pump focusing on:

🔶Infarct-related cardiogenic shock
🔶Hemodynamic support in high-risk PCI
🔶LV dysfunction management
🔶Coordinated care through shock networks

#JIMGISE2025 #interventionalcardiology
JIM Congress (@jimcongress) 's Twitter Profile Photo

🔥 Amazing first day at #JIMGISE2025! 🔥 Fellows Courses led dynamic debates, while the Virtual Tutored Operating Lab delivered exciting hands-on moments.💡💬🖐️ Thanks to all who made it unforgettable! 🙌 And this is just the beginning!💥 #FellowsCourse #VirtualLab #HandsOn

🔥 Amazing first day at #JIMGISE2025! 🔥

Fellows Courses led dynamic debates, while the Virtual Tutored Operating Lab delivered exciting hands-on moments.💡💬🖐️

Thanks to all who made it unforgettable! 🙌

And this is just the beginning!💥

#FellowsCourse #VirtualLab #HandsOn
Marco Toselli (@mrctsl) 's Twitter Profile Photo

2 complex LIVE cases on #modernPCI at JIM Congress ! 🔹 Both long, severely calcified LAD 1️⃣ #IVUS-guided #DCB 2️⃣ #IVUS-guided #ExcimerLaser Debating the best debulking strategy—insightful discussions ahead! #JIMGISE2025

2 complex LIVE cases on #modernPCI at <a href="/jimcongress/">JIM Congress</a> !

🔹 Both long, severely calcified LAD

1️⃣ #IVUS-guided #DCB
2️⃣ #IVUS-guided #ExcimerLaser

Debating the best debulking strategy—insightful discussions ahead!  #JIMGISE2025
JIM Congress (@jimcongress) 's Twitter Profile Photo

Day 2 at #JIMGISE2025 is here!💥 Get ready for an intense day of live cases, symposia, and the exciting Clinical Cases Competition! 🫀💡💬 Follow us on social media for real-time updates and the best highlights!📲 #LiveCases #ClinicalCases #Symposia #interventionalcardiology

Day 2 at #JIMGISE2025 is here!💥

Get ready for an intense day of live cases, symposia, and the exciting Clinical Cases Competition! 🫀💡💬

Follow us on social media for real-time updates and the best highlights!📲

#LiveCases #ClinicalCases #Symposia #interventionalcardiology
Jonathan Curio (@curiojonathan) 's Twitter Profile Photo

M-TEER beyond standard anatomies - F.Bedogni making the case for red zone TEER #JIMGISE2025 JIM Congress 🎯MR after surg VSD closure 🎯MR after surg chord rupture 🎯MR in small area+ severe MAC ➡️REPAIR & PRIMARY RCTs will evaluate new M-TEER indications of low/interm risk PMR

M-TEER beyond standard anatomies - F.Bedogni making the case for red zone TEER  #JIMGISE2025 <a href="/jimcongress/">JIM Congress</a>

🎯MR after surg VSD closure
🎯MR after surg chord rupture
🎯MR in small area+ severe MAC

➡️REPAIR &amp; PRIMARY RCTs will evaluate new M-TEER indications of low/interm risk PMR
Jonathan Curio (@curiojonathan) 's Twitter Profile Photo

Update on status & future #TMVR directions by Juan F. Granada #JIMGISE2025 JIM Congress 🎯devices evolved (single step (sub-)annular or multi step ring+valve w/cath profile⬇️) 🎯now safe, reproducible TS procedure ➡️Next years w/pivotal studies+approval of several device options

Update on status &amp; future #TMVR directions by <a href="/jgranadacrf/">Juan F. Granada</a> #JIMGISE2025 <a href="/jimcongress/">JIM Congress</a> 

🎯devices evolved (single step (sub-)annular or multi step ring+valve w/cath profile⬇️)
🎯now safe, reproducible TS procedure 

➡️Next years w/pivotal studies+approval of several device options
Radoslaw Parma (@parma) 's Twitter Profile Photo

#EAPCI joining #jimgise2025 🇮🇹 to explain: 1. When to FFR 📉 2. When to IVUS 🩻 3. When to OCT 💡 4. When to go wild with all of them 🔥 5. What to do in diffuse significant CAD? 🎈 6. How to make choices in ACS vs. CCS 🚨 Alessandro Sticchi tackled 50 audience questions! 😅 🎥

#EAPCI joining #jimgise2025 🇮🇹 to explain:

1. When to FFR  📉
2. When to IVUS 🩻
3. When to OCT 💡
4. When to go wild with all of them 🔥
5. What to do in diffuse significant CAD? 🎈
6. How to make choices in ACS vs. CCS 🚨

<a href="/Sticchi_Alex/">Alessandro Sticchi</a> tackled 50 audience questions! 😅

🎥
Jonathan Curio (@curiojonathan) 's Twitter Profile Photo

LAAO + M-TEER combo as #livecase from Uniklinik Bonn at #JIMGISE2025 JIM Congress ⭐️ 🎯puncture height chosen for good clipping, LAAO will work/follow by steering 🎯TEER first then LAAO ➡️combo safe & doable in reasonable amount of time

LAAO + M-TEER combo as #livecase from <a href="/UniklinikBonn/">Uniklinik Bonn</a> at #JIMGISE2025 <a href="/jimcongress/">JIM Congress</a> ⭐️

🎯puncture height chosen for good clipping, LAAO will work/follow by steering
🎯TEER first then LAAO
➡️combo safe &amp; doable in reasonable amount of time
JIM Congress (@jimcongress) 's Twitter Profile Photo

That’s a Wrap #JIMGISE2025 🙏to 145 faculty, 29 sponsors and 605 participants who made it special! 🙏to our Directors, Course Directors and SoMe for making it engaging and interactive! 👏Sara Ceni & Mihail Celeski for winning Best Clinical Case! See you at the next edition!🧡

That’s a Wrap #JIMGISE2025 
🙏to 145 faculty, 29 sponsors and 605 participants who made it special!
🙏to our Directors, Course Directors and SoMe for making it engaging and interactive!
👏Sara Ceni &amp; Mihail Celeski for winning Best Clinical Case!
See you at the next edition!🧡
FRANCESCO BURZOTTA (@burzotta_f) 's Twitter Profile Photo

The usefulness of kissing is always debated. One argument impossible to be challenged is the idea of ‘opening the door’ to SB territory. And it is not just a matter of struts. See this late neotissue coverage: acceptable by 2D #OCT and terrific at 3D #YESTOCT (in & out view)!

The usefulness of kissing is always debated. 
One argument impossible to be challenged is the idea of ‘opening the door’ to SB territory. And it is not just a matter of struts. See this late neotissue coverage: acceptable by 2D #OCT and terrific at 3D #YESTOCT (in &amp; out view)!